PLSE (STOCKS)
Pulse Biosciences, Inc Common Stock (DE)
$19.140000
+0.470000 (+2.52%)
Prev close: $18.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Paul A. LaViolette
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,287.10M
- Employees
- 75
- P/E (TTM)
- -17.52
- P/B (TTM)
- 15.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.26 | $-0.32 | +0.0562 | +17.77% |
|
Sep 2025 (Q3)
|
$-0.29 | $-0.32 | +0.0262 | +8.29% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.27 | +0.0652 | +24.59% |
|
Mar 2025 (Q1)
|
$-0.17 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $350.00K |
| Benefits Costs and Expenses | -$72.45M |
| Cost Of Revenue | $539.00K |
| Costs And Expenses | $77.29M |
| Gross Profit | -$189.00K |
| Nonoperating Income/Loss | $4.16M |
| Operating Expenses | $76.75M |
| Selling, General, and Administrative Expenses | $32.03M |
| Research and Development | $44.72M |
| Operating Income/Loss | -$76.94M |
| Income/Loss From Continuing Operations After Tax | $72.80M |
| Income/Loss From Continuing Operations Before Tax | $72.80M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$72.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$72.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$72.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.08 |
| Basic Average Shares | 67,395,339 |
| Assets | $94.54M |
| Current Assets | $83.42M |
| Inventory | $136.00K |
| Other Current Assets | $83.29M |
| Noncurrent Assets | $11.12M |
| Fixed Assets | $1.05M |
| Other Non-current Assets | $10.07M |
| Liabilities | $13.88M |
| Current Liabilities | $7.92M |
| Accounts Payable | $2.78M |
| Wages | $1.98M |
| Other Current Liabilities | $3.17M |
| Noncurrent Liabilities | $5.96M |
| Equity | $80.66M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $80.66M |
| Liabilities And Equity | $94.54M |
| Net Cash Flow From Operating Activities | -$54.12M |
| Net Cash Flow From Operating Activities, Continuing | -$54.12M |
| Net Cash Flow From Investing Activities | -$335.00K |
| Net Cash Flow From Investing Activities, Continuing | -$335.00K |
| Net Cash Flow From Financing Activities | $17.15M |
| Net Cash Flow From Financing Activities, Continuing | $17.15M |
| Net Cash Flow | -$37.30M |
| Net Cash Flow, Continuing | -$37.30M |
| Comprehensive Income/Loss | -$72.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$72.78M |
| Other Comprehensive Income/Loss | -$72.78M |